Showing results (81-90 of 321) with videos related to

Sort By:
Pageof 33
Nature Communications|March 1, 2016
Polycomb dysregulation in gliomagenesis targets a Zfp423-dependent differentiation networkElena Signaroldi, Pasquale Laise, Silvia Cristofanon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Cyclin D3 immunoreactivity is an independent predictor of survival in laryngeal squamous cell carcinomaGiancarlo Pruneri, Lorenzo Pignataro, Stefano Valentini, et al.
Cancer Medicine|March 20, 2023
Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinomaMarco Silvestri, Trung Nghia Vu, Federico Nichetti, et al.
Archives of Surgery (Chicago, Ill. : 1960)|October 4, 2002
Sentinel lymph node biopsy performed with local anesthesia in patients with early-stage breast carcinomaAlberto Luini, Giovanna Gatti, Antonio Frasson, et al.
International Journal of Cancer|June 12, 2003
Prognostic value of bcl-6, CD10 and CD38 immunoreactivity in stage I-II gastric lymphomas: identification of a subset of CD10+ large B-cell lymphomas with a favorable outcomeMaurilio Ponzoni, Andrés J M Ferreri, Giancarlo Pruneri, et al.
Hepato-Gastroenterology|June 27, 2007
Prognostic factors and outcome of resected patients for gastrointestinal stromal tumorsAntonio Chiappa, Andrew P Zbar, Roberto Biffi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 28, 2018
Ki-67 and presence of liver metastases identify different progression-risk classes in pancreatic neuroendocrine neoplasms (pNEN) undergoing resectionMassimo Milione, Patrick Maisonneuve, Alessio Pellegrinelli, et al.
Breast Cancer Research and Treatment|January 10, 2012
Methylation of O6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patientsCaterina Fumagalli, Giancarlo Pruneri, Paola Possanzini, et al.
Cancer Letters|May 7, 2021
Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancerFrancesca Ligorio, Ilaria Pellegrini, Lorenzo Castagnoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2005
Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapyGiovanni Martinelli, Daniele Laszlo, Andrés J M Ferreri, et al.
Pageof 33